Literature DB >> 32144561

Huayu Pill () Promotes Fluorescent Doxorubicin Delivery to Tumors in Mouse Model of Lung Cancer.

Lei Gao1, Cai-Xia Hao1, Gan-Lin Zhang1, Ke-Xin Cao1, Ming-Wei Yu1, Qi-Wei Li2, Xue-Man Ma2, Guo-Wang Yang1, Xiao-Min Wang3.   

Abstract

OBJECTIVE: To study the effect and mechanism of Huayu Wan (, HYW) in combination of chemotherapy of tumor treatment.
METHODS: HYW serum was added in Lewis cells to assess its impact on fluorescent doxorubicin delivery in vitro. Then, Lewis tumor cells was implanted in C57BL/6 mice via xenograft transplantation. Tumor growth was measured and signal intensity corresponding to blood flow was assessed by laser doppler perfusion imaging (LDPI). Finally, the effect of HYW on the effificacy of doxorubicin was studied.
RESULTS: HYW can improve the transfer of fluorescent doxorubicin into cells. The blood flow signal in the tumor tissues of the HYW group was higher than that of the control group (P<0.01). Furthermore, HYW improved drug delivery of doxorubicin to tumor tissues, and this activity was associated with HYW-induced microvascular proliferation (P<0.01).
CONCLUSIONS: HYW can promote microangiogenesis and increase blood supply in tumor tissues, which in turn may increase the risk of metastasis. At the same time, HYW increases drug delivery and improves the effificacy of chemotherapy drugs through vascular proliferation. Therefore, rational judgment must be exercised when considering applying HYW to an antitumor regimen.
© 2020. The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Chinese medicine; Huayu Wan; drug delivery; fluorescent doxorubicin

Year:  2020        PMID: 32144561     DOI: 10.1007/s11655-020-3191-7

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  1 in total

1.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

  1 in total
  3 in total

1.  Huayu Wan Prevents Lewis Lung Cancer Metastasis in Mice via the Platelet Pathway.

Authors:  Yunfei Ma; Guangda Li; Xu Sun; Kexin Cao; Xiaomin Wang; Guowang Yang; Mingwei Yu
Journal:  Evid Based Complement Alternat Med       Date:  2020-07-27       Impact factor: 2.629

2.  Lentinan combined with cisplatin for the treatment of non-small cell lung cancer.

Authors:  Chenchen Zhao; Haifeng Yan; Wentai Pang; Tong Wu; Xianbin Kong; Xiaojiang Li; Honggen Liu; Linlin Zhao; Feng Liang; Yingjie Jia
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

3.  Integrated Network Pharmacology and Experimental Verification to Explore the Molecular Mechanism of Hedysarum Multijugum Maxim-Curcumae Rhizoma Herb Pair for Treating Non-Small Cell Lung Cancer.

Authors:  Shaopu Hu; Mengxue Ge; Shuixiu Zhang; Min Jiang; Kaiwen Hu; Lei Gao
Journal:  Front Oncol       Date:  2022-03-30       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.